This article has been corrected: The correct author name is given below:
Alfredo Minguela
Original article: Oncotarget. 2017; 8:31959-31976. https://doi.org/10.18632/oncotarget.16657
. 2018 Aug 28;9(67):32881. doi: 10.18632/oncotarget.26079
Correction: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Aroa Baragaño Raneros
1, Alfredo Minguela
2, Ramon M Rodriguez
1, Enrique Colado
3, Teresa Bernal
3, Eduardo Anguita
4, Adela Vasco Mogorron
2, Alberto Chaparro Gil
4, Jose Ramon Vidal-Castiñeira
1, Leonardo Márquez-Kisinousky
1, Paula Díaz Bulnes
1, Amelia Martinez Marin
5, Maria Carmen García Garay
6, Beatriz Suarez-Alvarez
1,*, Carlos Lopez-Larrea
1,*
Aroa Baragaño Raneros
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Aroa Baragaño Raneros
Alfredo Minguela
2 Immunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
Find articles by Alfredo Minguela
Ramon M Rodriguez
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Ramon M Rodriguez
Enrique Colado
3 Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Enrique Colado
Teresa Bernal
3 Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Teresa Bernal
Eduardo Anguita
4 Hematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain
Find articles by Eduardo Anguita
Adela Vasco Mogorron
2 Immunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
Find articles by Adela Vasco Mogorron
Alberto Chaparro Gil
4 Hematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain
Find articles by Alberto Chaparro Gil
Jose Ramon Vidal-Castiñeira
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Jose Ramon Vidal-Castiñeira
Leonardo Márquez-Kisinousky
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Leonardo Márquez-Kisinousky
Paula Díaz Bulnes
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Paula Díaz Bulnes
Amelia Martinez Marin
5 Hematology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
Find articles by Amelia Martinez Marin
Maria Carmen García Garay
6 Hematology Service, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain
Find articles by Maria Carmen García Garay
Beatriz Suarez-Alvarez
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Beatriz Suarez-Alvarez
Carlos Lopez-Larrea
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
Find articles by Carlos Lopez-Larrea
1 Department of Immunology, Hospital Universitario Central de Asturias, Oviedo, Spain
2 Immunology Service, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
3 Department of Hematology, Hospital Universitario Central de Asturias, Oviedo, Spain
4 Hematology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Department of Medicine, Universidad Complutense de Madrid (UCM), Madrid, Spain
5 Hematology Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
6 Hematology Service, Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain
*
These authors have contributed equally to this work
Collection date 2018 Aug 28.
Copyright: © 2018 Baragaño Raneros et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PMCID: PMC6132351 PMID: 30214691
This corrects the article "Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition" in volume 8 on page 31959.